Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy
Identifieur interne : 000742 ( Main/Exploration ); précédent : 000741; suivant : 000743Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy
Auteurs : Heather M. Kling ; Gerard J. Nau ; Ted M. Ross ; Thomas G. Evans ; Krishnendu Chakraborty ; Kerry M. Empey ; Joanne L. FlynnSource :
- Annals of the American Thoracic Society [ 2329-6933 ] ; 2014.
Abstract
Pulmonary diseases and infections are among the top contributors to human morbidity and mortality worldwide, and despite the successful history of vaccines and antimicrobial therapeutics, infectious disease still presents a significant threat to human health. Effective vaccines are frequently unavailable in developing countries, and successful vaccines have yet to be developed for major global maladies, such as tuberculosis. Furthermore, antibiotic resistance poses a growing threat to human health. The “Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy” session of the 2013 Pittsburgh International Lung Conference highlighted several recent and current studies related to treatment and prevention of antibiotic-resistant bacterial infections, highly pathogenic influenza, respiratory syncytial virus, and tuberculosis. Research presented here focused on novel antimicrobial therapies, new vaccines that are either in development or currently in clinical trials, and the potential for immunomodulatory therapies. These studies are making important contributions to the areas of microbiology, virology, and immunology related to pulmonary diseases and infections and are paving the way for improvements in the efficacy of vaccines and antimicrobials.
Url:
DOI: 10.1513/AnnalsATS.201401-036PL
PubMed: 25148426
PubMed Central: 4200570
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000607
- to stream Pmc, to step Curation: 000607
- to stream Pmc, to step Checkpoint: 000529
- to stream Ncbi, to step Merge: 000A77
- to stream Ncbi, to step Curation: 000A77
- to stream Ncbi, to step Checkpoint: 000A77
- to stream Main, to step Merge: 000743
- to stream Main, to step Curation: 000742
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy</title><author><name sortKey="Kling, Heather M" sort="Kling, Heather M" uniqKey="Kling H" first="Heather M." last="Kling">Heather M. Kling</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author><author><name sortKey="Nau, Gerard J" sort="Nau, Gerard J" uniqKey="Nau G" first="Gerard J." last="Nau">Gerard J. Nau</name><affiliation><nlm:aff id="aff2"></nlm:aff></affiliation><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Ross, Ted M" sort="Ross, Ted M" uniqKey="Ross T" first="Ted M." last="Ross">Ted M. Ross</name><affiliation><nlm:aff id="aff4"></nlm:aff></affiliation></author><author><name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name><affiliation><nlm:aff id="aff5"></nlm:aff></affiliation></author><author><name sortKey="Chakraborty, Krishnendu" sort="Chakraborty, Krishnendu" uniqKey="Chakraborty K" first="Krishnendu" last="Chakraborty">Krishnendu Chakraborty</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Empey, Kerry M" sort="Empey, Kerry M" uniqKey="Empey K" first="Kerry M." last="Empey">Kerry M. Empey</name><affiliation><nlm:aff id="aff6"></nlm:aff></affiliation></author><author><name sortKey="Flynn, Joanne L" sort="Flynn, Joanne L" uniqKey="Flynn J" first="Joanne L." last="Flynn">Joanne L. Flynn</name><affiliation><nlm:aff id="aff2"></nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25148426</idno><idno type="pmc">4200570</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200570</idno><idno type="RBID">PMC:4200570</idno><idno type="doi">10.1513/AnnalsATS.201401-036PL</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">000607</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000607</idno><idno type="wicri:Area/Pmc/Curation">000607</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000607</idno><idno type="wicri:Area/Pmc/Checkpoint">000529</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000529</idno><idno type="wicri:Area/Ncbi/Merge">000A77</idno><idno type="wicri:Area/Ncbi/Curation">000A77</idno><idno type="wicri:Area/Ncbi/Checkpoint">000A77</idno><idno type="wicri:doubleKey">2329-6933:2014:Kling H:challenges:and:future</idno><idno type="wicri:Area/Main/Merge">000743</idno><idno type="wicri:Area/Main/Curation">000742</idno><idno type="wicri:Area/Main/Exploration">000742</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy</title><author><name sortKey="Kling, Heather M" sort="Kling, Heather M" uniqKey="Kling H" first="Heather M." last="Kling">Heather M. Kling</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author><author><name sortKey="Nau, Gerard J" sort="Nau, Gerard J" uniqKey="Nau G" first="Gerard J." last="Nau">Gerard J. Nau</name><affiliation><nlm:aff id="aff2"></nlm:aff></affiliation><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Ross, Ted M" sort="Ross, Ted M" uniqKey="Ross T" first="Ted M." last="Ross">Ted M. Ross</name><affiliation><nlm:aff id="aff4"></nlm:aff></affiliation></author><author><name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name><affiliation><nlm:aff id="aff5"></nlm:aff></affiliation></author><author><name sortKey="Chakraborty, Krishnendu" sort="Chakraborty, Krishnendu" uniqKey="Chakraborty K" first="Krishnendu" last="Chakraborty">Krishnendu Chakraborty</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Empey, Kerry M" sort="Empey, Kerry M" uniqKey="Empey K" first="Kerry M." last="Empey">Kerry M. Empey</name><affiliation><nlm:aff id="aff6"></nlm:aff></affiliation></author><author><name sortKey="Flynn, Joanne L" sort="Flynn, Joanne L" uniqKey="Flynn J" first="Joanne L." last="Flynn">Joanne L. Flynn</name><affiliation><nlm:aff id="aff2"></nlm:aff></affiliation></author></analytic><series><title level="j">Annals of the American Thoracic Society</title><idno type="ISSN">2329-6933</idno><idno type="eISSN">2325-6621</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Pulmonary diseases and infections are among the top contributors to human morbidity and mortality worldwide, and despite the successful history of vaccines and antimicrobial therapeutics, infectious disease still presents a significant threat to human health. Effective vaccines are frequently unavailable in developing countries, and successful vaccines have yet to be developed for major global maladies, such as tuberculosis. Furthermore, antibiotic resistance poses a growing threat to human health. The “Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy” session of the 2013 Pittsburgh International Lung Conference highlighted several recent and current studies related to treatment and prevention of antibiotic-resistant bacterial infections, highly pathogenic influenza, respiratory syncytial virus, and tuberculosis. Research presented here focused on novel antimicrobial therapies, new vaccines that are either in development or currently in clinical trials, and the potential for immunomodulatory therapies. These studies are making important contributions to the areas of microbiology, virology, and immunology related to pulmonary diseases and infections and are paving the way for improvements in the efficacy of vaccines and antimicrobials.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Chakraborty, Krishnendu" sort="Chakraborty, Krishnendu" uniqKey="Chakraborty K" first="Krishnendu" last="Chakraborty">Krishnendu Chakraborty</name><name sortKey="Empey, Kerry M" sort="Empey, Kerry M" uniqKey="Empey K" first="Kerry M." last="Empey">Kerry M. Empey</name><name sortKey="Evans, Thomas G" sort="Evans, Thomas G" uniqKey="Evans T" first="Thomas G." last="Evans">Thomas G. Evans</name><name sortKey="Flynn, Joanne L" sort="Flynn, Joanne L" uniqKey="Flynn J" first="Joanne L." last="Flynn">Joanne L. Flynn</name><name sortKey="Kling, Heather M" sort="Kling, Heather M" uniqKey="Kling H" first="Heather M." last="Kling">Heather M. Kling</name><name sortKey="Nau, Gerard J" sort="Nau, Gerard J" uniqKey="Nau G" first="Gerard J." last="Nau">Gerard J. Nau</name><name sortKey="Ross, Ted M" sort="Ross, Ted M" uniqKey="Ross T" first="Ted M." last="Ross">Ted M. Ross</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000742 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000742 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:4200570
|texte= Challenges and Future in Vaccines, Drug Development, and Immunomodulatory Therapy
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25148426" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |